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Worldwide molecular
epidemiology of HIV
Epidemiologia molecular do HIV no
mundo
ABSTRACT
Human immunodeficiency virus (HIV) is the worldwide disseminated causative
agent of acquired immunodeficiency syndrome (AIDS). HIV is a member of the
Lentivirus genus of Retroviridae family and is grouped in two types named HIV-1
and HIV-2. These viruses have a notable ability to mutate and adapt to the new
conditions of human environment. A large incidence of errors at the transcriptional
level results in changes on the genetic bases during the reproductive cycle. The
elevated genomic variability of HIV has carried important implications for the diagnosis,
treatment and prevention as well as epidemiologic investigations. The present review
describes important definitions and geographical distribution of subtypes, circulating
recombinant forms and other genomic variations of HIV. The present study aimed at
leading students of Biomedical Sciences and public health laboratory staff guidance
to general and specific knowledge about the genomic variability of the HIV.
KEYWORDS: HIV, genetics. HIV infections, epidemiology. Acquired
immunodeficiency syndrome, epidemiology. HIV subtypes. Circulating
recombinant forms.
RESUMO
O vírus da imunodeficiência humana (HIV), disseminado em todo o mundo, é o
agente responsável pela síndrome da imunodeficiência adquirida (Aids). O HIV é
um membro do gênero Lentivirus da família Retroviridae e compreende os tipos HIV-
1 e HIV-2. Esses vírus possuem notável capacidade de mutar e se adaptar às novas
condições do ambiente humano. Uma grande incidência de erros ao nível transcricional
do genoma resulta em alterações nas bases genéticas durante o ciclo reprodutivo. A
elevada variabilidade genômica do HIV apresenta importantes implicações para o
diagnóstico, tratamento e prevenção, bem como nas investigações epidemiológicas.
A elaboração desta revisão traz importantes conceitos sobre definições e distribuição
geográfica de subtipos, formas recombinantes circulantes e outras variações genômicas
do HIV. O estudo pretendeu direcionar os estudantes de ciências biomédicas e os
profissionais de laboratórios de saúde pública aos conhecimentos gerais e específicos
acerca da variabilidade genômica do HIV.
DESCRITORES: HIV, genética. Infecções por HIV, epidemiologia. Síndrome
de imunodeficiência adquirida, epidemiologia. Subtipos de HIV. Formas
recombinantes circulantes.
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INTRODUCTION
The causative agent of acquired immunodeficiency
syndrome (AIDS) is the worldwide disseminated hu-
man immunodeficiency virus (HIV). About 85% of the
HIV isolates from humans are grouped into two types,
HIV-1 and HIV-2. The worldwide main agent of AIDS is
HIV-1, while the occurrence of HIV-2 is restricted to
some regions of Western and Central Africa.
HIV and simian immunodeficiency virus (SIV) are
genetically related members of Lentivirus genus of
the Retroviridae family. Lentiviruses include com-
plex exogenous viruses responsible for a variety of
neurological and immunological diseases, but not
directly implicated in any malignancies. Genomes of
these viruses are characterized by structural genes
gag, pol, env, and a complex combination of other
additional genes. The retrovirus genome is unique
among viruses in several aspects, including its physi-
cal organization, its mode of synthesis, and its func-
tions in replication. The diploid virus genome is com-
posed of two identical copies of single-strand ribo-
nucleic acid (RNA) and is synthesized and processed
by the host cell messenger RNA (mRNA) handling
machinery.43,80
Distinct lentiviruses have been isolated from several
nonhuman primate species including African green
monkeys (SIV
AGM
), sooty mangabeys (SIV
SMM
), man-
drills (SIV
MND
), sykes (SIV
SYK
), and chimpanzees
(SIV
CPZ
). Several SIV have also been isolated from
Asian macaque species including SIV from Rhesus
macaques (SIV
MAC
), nemestrine macaques (SIV
MNE
),
and stump-tailed macaques (SIV
STM
). In these pri-
mates, the SIVs cause endemic AIDS-like disease.
Despite extensive genomic diversity, a unifying fea-
ture of human and nonhuman primate lentiviruses is
that the cell receptor is the CD4 antigen, a differen-
tiation marker on the surface of T-helper
lymphocytes.43,44,53,58,97,107
At present, the origins of HIV-1 and HIV-2 infections
remain an enigma, although some investigations have
indicated that both viruses have risen from zoonotic
transmissions between nonhuman primates and hu-
mans.97 The analysis of genetic sequencing has re-
vealed that the genomes of SIV
SMM
 and HIV-2 exhibit
a high degree of homology although SIV
CPZ
 is most
closely related to HIV-1 strain.41,45,52,53,59 HIV-2 has a
genetic structure very similar to HIV-1 but a nucle-
otide homology46 of only 60%.
Several authors have admitted that humans are not
the natural host of either HIV-1 or HIV-2. Instead, these
viruses have entered the human population as a re-
sult of zoonotic or cross-species transmission. Afri-
can primates represent an extremely large reservoir
of lentiviruses with the potential for infecting other
species, including humans, in their natural habitats.
Probably, there was a certain moment in which two
different SIV strains infected and replicated in a chim-
panzee, originating thus the recombinant virus now
named HIV. That proves their biological fitness by
becoming major circulating forms of epidemiologi-
cal significance, capable of infecting humans and
causing AIDS epidemic. Many of the SIVs known to
infect mainly chimpanzees exhibit biological prop-
erties that render them at least candidates for natural
transmission to humans, such as the ability to repli-
cate efficiently in primary human lymphocytes.7,47,53
When did HIV-1 enter humans, and when did the cur-
rent phylogeny of HIV-1 genotypes arise have been
extremely controversial questions. Studies using lin-
ear distance-time correlations estimate that HIV-1 first
diverged from HIV-2 around 1930 and then diverged
to its current phylogeny over the past 40 years. In the
evolutionary origin of HIV and SIV it is estimated
that the HIV-1/HIV-2 divergence node occurred in the
early 1,800s and, the oldest node linking all human
and simian viruses date back 600 to 1,200 years, while
the HIV-1 strain causing AIDS were estimated to be
50 to 100 years old.36,44,45,77-79,97
Studying HIV genetic variation at the global level is
needed, not only to learn the origins and understand
the epidemiology of HIV-1, but also the emergence
of subtypes, Circulating Recombinant Forms (CRFs),
and intra-subtypes that may be more readily trans-
mitted or have altered virulence, and to ensure that
vaccine antigens are directed against strains of the
virus that are currently circulating within specific
populations.
GENOMIC VARIABILITY
HIV presents a remarkable ability to mutate and adapt
to the new conditions of the human environment. A
large incidence of errors at transcriptional level re-
sults in changes on the genetic bases during the re-
productive cycle of HIV. Reverse transcriptase plays
a major role in generation of diversity of retroviruses.
Several error mechanisms have been ascribed to
polymerases in general, and a high frequency of mu-
tations occurs including genetic substitutions, dele-
tions, recombinations, repetitions, and insertions.
Each of these events may involve one or more
nucleotides. By reason of these various error mecha-
nisms, in addition to the recombinant events, reverse
transcriptase plays a distinguished role for produc-
ing HIV sequence diversity in infected individuals.
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The elevated genomic variability of HIV gives raise
to important implications for laboratory diagnosis,
treatment, prevention, and for epidemiological in-
vestigation as well.80,109
Replication of HIV, like all RNA viruses that lack
enzymes for editing the freshly replicated nucleotides
strands, is liable to error prone.113 HIV-1 generates, on
average, one error per 104 nucleotides, which is also
the size of its genome. Potentially, each provirus is a
new mutant strain, unique at least in one base site.
Mutations accumulate over successive replication
cycles, leading to a myriad of closely related but non-
identical viruses in every infected individual. Blood
and lymphoid tissue from a HIV-infected human adult
individual contains 1011 CD4-positive lymphocytes,
of which between 109 and 1010 can be showed to harbor
viral DNA. On account of 107 HIV-infected patients
worldwide, there may be as many as 1017 HIV geneti-
cally unique strain variants in circulation. This vast
reservoir of genetic variants may increase the poten-
tial for successful adaptation of the HIV-1
strains.64,74,79,92 Antiviral immune responses and other
factors, such as cell tropism and cytopathicity, pro-
vide selective pressure for accumulation of viral vari-
ants, designated quasi-species, in the host. The quasi-
species is the realization of the distribution of forms
within the sequence space. The term quasi-species
has come to be used more loosely in the HIV litera-
ture to simply refer to the set of viruses found in an
infected individual. Under circumstances of selec-
tive pressure, such as therapy or immune pressure,
the frequency of forms in the viral population can be
shifted.34,65,111,112
SUBTYPES
Human immunodeficiency virus type-1 (HIV-1) is
classified into three distinct groups: M (major), O
(outlier) and N (non M/non O, new). Groups M, N and
O viruses are members of primate Lentivirus lineage
that includes also SIV
CPZ
 strains. In Lentivirus line-
age, groups M and N, and SIV
CPZ
, are approximately
equidistant from each other, whereas group O is the
most distantly related to the other strains.41 HIV-1
group M has spread worldwide, causing the global
AIDS pandemic. Group O infections are less com-
mon, and they have been endemic in West Central
Africa mainly in Cameroon, Gabon, Nigeria, and
Equatorial Guinea. This group has early been identi-
fied in Africa and spread in Europe and the United
States, however, most of infections due to group O
might be directly linked to persons who had had any
connection to West Central Africa. Group O has been
accounted for less than 10% of HIV-1 infections
worldwide.5,23,24,41,60,125,151-153
The earliest case of HIV-1 group M infection was iden-
tified in human blood specimen collected in 1959 in
Kinshasa, Democratic Republic of Congo157,158 while
the most ancient case of group O infection was found
in a Norwegian patient that would be infected in the
early 1960s.60,138 Group N infections have been iden-
tified in West Central Africa, only in some people
from Cameroon.5,23,125
Since the introduction into humans, group M has been
described as a major phylogenetic entity of HIV-1.
Group M is composed of 11 subtypes or clades named
A through K, besides more than 15 CRFs which circu-
late among varying extents in populations around the
globe. In relation to the group O, there is no analogous
classification of subtypes, however it has been pro-
posed a classification into five phylogenetic clusters
designated from I to V. HIV-2 also presents variants that
are classif ied into f ive distinct and equidistant
subtypes named from A to E.151,152
Subtype designations have been powerful molecular
epidemiological markers to track the course of the
HIV-1 epidemic. The subtypes of group M are geno-
typic variants defined mainly in function of sequence
variation in env gene, which encodes the glycopro-
tein gp120 in virion membrane. Regions of pol, gag
and vif genes are also sequenced to characterize the
subtypes.88,89,138 The subtypes of group M are equi-
distant from each other in a radial phylogenetic dis-
tribution from a common ancestor.117,151,152
The next conditions are proposed for establishing
the subtypes of a virus isolate: (a) at least two isolates
should be sequenced in their entireties, (b) they
should resemble each other but not to other existing
subtypes throughout the genome, and (c) they should
have to be found in at least three epidemiologically
unlinked individuals.117
In order to make easier the vaccine design and evalu-
ation, several programs for typing the HIV-1 isolates
have been implemented mainly for countries suit-
able as sites for conducting the phase III vaccine
efficacy trials.35 For these proposals, the employed
techniques include serotyping,137 heteroduplex
mobility assay (HMA),14,30,31 RT-polymerase chain
reaction (RT-PCR)-gag fingerprinting50,73,85,118,145 and
lately DNA microarray assays have been introduced
for this purpose.124
The HIV subtyping has been an important molecular
tool for monitoring the geographic changes in world-
wide AIDS epidemic. Existence of significant differ-
ences in HIV subtypes-associated pathogenesis or
transmissibility has still to be determined. The de-
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gree to which the vaccines based on one subtype will
elicit cross-protection against other subtypes is still
poorly understood. However, there is well-established
evidence that differences related to diagnostic assays
performance and to antiretroviral drugs efficiency do
exist among the several HIV-1 variants. Therefore, it
remains important to track the HIV-1 molecular epi-
demiology and the genetic characterization of preva-
lent HIV-1 strains.30,31
According to genetic sequencing study of group M,
the subtypes A to K have been regionally dispersed.
The subtype A has been responsible for 80% of the
HIV-infections in Western Africa, and for 30% in East-
ern Africa.54,89 In Eastern Europe the subtype A has
been disseminating since 1995 in the countries from
the Former Soviet Union, mainly Russia and
Ukraine.12,83,98
HIV subtype B has been the main epidemic compo-
nent in the Western Europe (60%), together with
subtype A (11%), C (5%) and other subtypes
(11%).32,50,51,130,134 Subtype B is also predominant in
Americas,78,79,144 and in the Australian continent,48 and
also in some Asian countries as Korea,102 India and
Singapure.122 In Japan,66,146 where the subtype B has
been predominant (74%), other subtypes such as C
(3.5%), A (2.0%), F (1.0%) are also circulating to-
gether with subtype E (20%).
Subtype C represents 60% of HIV-infections world-
wide, predominantly in East Africa and South
Asia.20,69,77,83 Subtype C has been reported in Malay-
sia and Southwest China, which may reflect the virus
spreading via links with India where this subtype pre-
dominate.20,25,110,136 In Tanzania (Africa)3 subtype C
shows 50% prevalence followed by subtypes A and
B. Recent epicenter of HIV subtype C has been veri-
fied in Southern Africa involving Botswana, Zimba-
bwe, Malawi, Zambia, Namibia, South Africa and it
has spread to India, Nepal and China. In Europe
subtype C has also increased in Scotland since 2000,
mainly due to transmission from individuals with
evident exposure outside the United Kingdom such
as African and Asian countries.153
Subtype D has been responsible for 5 to 40% in coun-
tries of East and Central Africa where it has been cir-
culating together with subtype A.74,109 Subtype E (re-
named as CRF01_AE) has been common in Vietnam
and neighbor countries, in the majority of infected
intravenous drug users (IDUs).22,71 Subtype E has been
predominant in Thailand (>80%), with small propor-
tion of subtype B, also in majority of IDUs.22,129
Subtype F has been the most common virus in East-
ern Europe, mainly in Romenia,104 and is also con-
stituent part of Southern American subtypes.114,116
Subtype I was first identified in Cyprus and Greece
in the early 1990s and from there it has spread to the
Mediterranean Region.71,105
The subtypes A, E, G, H, J and K have been described
to be prevalent in Burkina Faso, Mali, Nigeria, Ivory
Coast, Gabon, and Democratic Republic of Congo,
from where they have spread to South Europe, and
Asia.6,16,55,89,106,122
In South America, HIV-1 subtype B has been predomi-
nant in Brazil, followed by subtypes F, and C, with
small proportion of subtype D.13,15,28,30,39,94,114,116,127 In
Argentina, Bolivia, Peru, Paraguay, Uruguay and Ven-
ezuela21 and also in Caribbean Islands140 these same
subtypes have been found since the mid-1990s.
The main cells targeted by HIV in vivo are T-
lymphocytes, macrophages and probably dendritic
cells. This tropism is predominantly determined by
the cell surface receptors required for HIV to attach to
and gain entry into cells. Usually, entry to target cells
requires both CD4 and one of the chemokine
coreceptors. Chemokine CCR5 is the coreceptor pre-
dominantly used in vivo, however, variants that use
another coreceptor CXCR4 evolve during disease in
some AIDS patients.26 Several reports indicate that
HIV-1 subtypes present different immunobiological
properties. Subtypes A and D differ in ratio for
coreceptor usage. Most subtype A isolates use the
CCR5 receptor tropism for attaching to T-cells. In
contrast, most subtype D isolates use the CXCR4
coreceptor. However the dual CCR5/CXCR4 tropism
has not been observed among them yet.88
Recent observation in Senegal showed that the time
for disease progression in HIV-1 subtype A-infected
has been slower than in non-A subtype-infected indi-
viduals.62 In contrast, subtype A is associated with a
higher risk for vertical transmission than subtype D.115
Results obtained from Sub-Saharan Africa have sug-
gested that HIV-1 subtypes A, C, D, and E are well
adapted for heterosexual transmission while subtype
B is less efficiently transmitted by this route. On the
other hand, in North America, Western Europe, South
Asia and India, subtype B is efficiently transmitted
by intravenous drug users, and among homosexual
individuals, in whom the infection by HIV-1 subtypes
A, C, D and E does not occur.1,49,59,68
CIRCULATING RECOMBINANT FORMS
When two distinct HIV-1 strains are circulating, and
these strains are initially introduced into different
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social networks but these barriers eventually can col-
lapse, the two virus strains become highly intermixed
in an individual, establishing conditions for inter-
subtypes recombination.4,117 If a individual is in-
fected by two different HIV-1 subtypes, and if the
resultant genetic combination is satisfactorily es-
tablished in the environment, then this is designated
CRF. Currently, about 20 CRFs have been described
and numbered according to the order in which they
have adequately described. As example, the desig-
nation CRF01_AB indicates the first occurrence of
CRF in a person, a recombinant strain composed of
two subtypes, A and B, which have been genetically
recombined.19,69,116
On the basis of the newly proposed nomenclature,
the formal requirement for assigning a new CRF is
the existence of at least three epidemiologically in-
dependent complete genomic sequences that share
the same recombinant structure, and form a mono-
phyletic cluster in all regions of the genome. Or it
should produce two full-length genome sequences
plus partial sequences of a third strain that cluster
with full-length genome sequences, and share iden-
tical breakpoints. Monophyletic groups (or clades)
are defined as groups containing species which are
more closely related to each other than to any out-
side of the group.116,117
CRF occurrence varies worldwide and sometimes dif-
fers according to the local or regional predominant
subtypes. In a geographic region, the proportion of
recombinant virus emergence depends on a series of
factors, including (a) the prevalence index of the dif-
ferent virus subtypes, (b) the probability in which
certain population groups acquire multiple infections,
and the chance of these viruses being further trans-
mitted, and (c) the occurrence of generation of ge-
nomic recombinations. Once these factors occur re-
combination can still be broken and then the fre-
quency of pure subtype is likely to increase. Recom-
bination may introduce genetic and biological con-
sequences that are better than those resulting from
firm accumulation of single mutations. From this, it
is conceivable to presume what kind of impact the
diversity caused by CRF structures may have over
the development of highly efficacious HIV/AIDS
vaccines. HIV-1 subtypes and CRF dissemination
have been a dynamic and unpredictable process, and
the geographical spreading of these ongoing virus
variants has been unpreventable.35,131,148
The generation of intersubtype recombinant HIV-1
may occur in a setting of intermixing of subtypes
and their recombinants in populations, with many
cycles of co-infection and back-crossing before ex-
trinsic factors such as geographic dispersal, or entry
into a different social network, lead to “fixation” of
particular recombinant forms.117 In Kaliningrad,
Russia, in mid-1990s, an epidemic among IDUs in-
volved recombinant viruses that are mosaics of dis-
seminated subtypes A and B from the Former Soviet
Union. This virus, which was designated CRF03_AB,
has spread all over East Europe. Subtype A and B
strains from Ukrainian IDUs were showed to be the
probable parental viruses of the Kaliningrad AB
recombinant strain.76,99
A complex mosaic of alternating subtype A and
subtype G sequences, with origin in Ibadan, Nigeria,
was recognized as CRF02_AG. This virus emerged
among several African countries and became epi-
demic in the African continent, predominantly in West
and West Central Africa, where it represents between
50 to 70% of the circulating strains.2,24,38,83,91,109,143
Thus, from Africa CRF02_AG they were introduced
in Europe and its epidemic has lately been rapidly
spreading in France,137 Belgium,126 Italy,90 and United
Kingdom.134 African and European immigrants are
responsible by a large panel of CRFs in United King-
dom, such as CRF01_AE, CRF14_BG, CRF03_AB,
CRF05_DF, CRF06_cpx, and CRF11_cpx, together
with CRF02_AG and several URFs.2,43,82,143
In China where circulates an Indian subtype C in ad-
dition to a Chinese subtype B variant (B
Ch
), mainly
among IDUs, the recombination of both viruses gen-
erated two new B/C recombinants, CRF07_BC and
CRF08_BC. The CRF07_BC appears to contain two
small subtype C segments interspersed with subtype
B (a C/B/C configuration). CRF08_BC seem to have
a B/C/B configuration with a long subtype C seg-
ment interrupted by small, closely spaced subtype B
segments. Probably, in a certain time, a “parental”
BC recombinant should have arise and widely dis-
persed. Then, different individuals with such a BC
strain could have become co-infected with subtype
C, generating recombinants of different but related
structure in two separate backcrosses (the cross of F1
hybrid to one of the parental types). The shared break-
points of CRF07_BC and CRF08_BC offsprings may
be those that were retained from the “parental” BC
recombinant. As the two CRFs became dispersed geo-
graphically, moving away from the main concentra-
tions of both subtype C and subtype B, further
backcrossing may have been curtailed, fixing these
strains in the population.85,132,145,155 In Thailand, the
frequency of subtype B increased in early-1990s
mainly among IDUs and, by the end of that decade,
its decrease was observed just when the prevalence
of subtype C began to increase and, at the same time,
the emergence of Indian subtypes E and F was recog-
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nized, thereof the new recombinants BC, BE and BF
became predominant.83
In Portugal, there has been a potential spreading of
multiple CRFs owing to the return of native Portu-
guese people from former Portuguese colonies in
Africa, where they lived or worked. In this way, Eu-
ropean HIV-1 subtype B may recombinate with Afri-
can subtypes A, C, D, G, H, and J from Angola, Mo-
zambique and Guinea Bissau.37 In Spain, as occurred
in Portugal, European subtype B might also be
recombinated with African subtypes A and J brought
from the former Spanish colony of Equatorial
Guinea.18, 54
In Argentina, Uruguay, and Brazil the CRF12_BF
became prevalent in heterosexual population, and in
vertically infected children.17,36,51,114,116,120,121 In Bra-
zil, the distribution of HIV-1 subtypes assumes diver-
sified patterns according to the geographic regions.
In the Brazilian Southern and Southeastern States the
rate of subtype B arise to 50%, and subtypes C and F
represent 28% and 7%, respectively,127 while in North-
eastern region occurs a high prevalence of B (>80%)
followed by a low frequency (<3%) of subtype F and
BC recombinant.39 Other recombinant forms such as
B/C, C/B, B/F, F/D, and the triplet B/C/F are consist-
ent with the three main circulating subtypes.74,94,116,127
The genetic arrangement caused by the subtype
recombinations has made it difficult the understand-
ing of CRF genomic composition, and then its ensu-
ing definition. All representing subtype E strains ini-
tially described in Southeast Asia seem to be
recombinant forms of subtypes A and E, and thus they
have been designated CRF01_AE. Genetic
sequencing of this strain is divergent from a subtype
A in the env gene, parts of vif, vpr, and nef genes and
the LTR. However, a full-length non-recombinant
subtype E sequence has not been described yet, and
the absence of one of the “parental” lineages makes
it difficult to formally proving the recombinant na-
ture of these viruses. By this sense, it has not been
considered as subtype E for A-K classification. In spite
of CRF01_AE being an incorrect name because the
putative “parental” non-recombinant E strain has not
been found, as the “E” designation for env region of
these strains is very common used, renaming it would
lead to confusion. Thus, the “E” designation will be
retained for the viruses CRF01_AE.2,117
CRF01_AE viruses have been documented at low
frequencies in several Central African countries, like
Central African Republic, Cameroon and the Demo-
cratic Republic of Congo.100,102,141 However they are
responsible for the explosive epidemic in Southeast
Asia, especially in Thailand from where these vi-
ruses have further spread to surrounding countries
like Vietnam,64,87 Cambodia,88 Myanmar,95 China,146
and Taiwan.25
Genomes in mosaic forms, containing sequences origi-
nated from more than two subtypes have been named
by replacing “cpx,” denoting complex. Subtype I, from
Greece and Cyprus71,105 has not still been recognized
as a full-length genome. This virus resembles a mosaic
of subtypes A, G, H and K, and a putative new subtype
I. Thus, subtype I was removed from the genetic classi-
f ication of subtypes A-K and it is now called
CRF04_cpx.40,101,117 Due to the renaming of subtype E
as CRF01_AE and the subtype I as CRF04_cpx, in
contrast to 11 subtypes A-K, several authors have ad-
mitted only nine subtypes of HIV-1 in the group M,
then designated A-D, F-H, J and K.79,82,96,106,117
Others important “cpx” include CRF-06_cpx from
Burkina Faso and Mali that is composed of succes-
sive fragments of subtypes A, G, J and K. CRF09_cpx
described in Senegal is composed of circulating
subtypes A, C and D. CRF11_cpx comprising subtypes
A, G, J, and fragments of CRF01_AE was observed in
Cameroon and the Central African Republic.
CRF13_cpx was recently also found in Cameroon
and is a mosaic of genomic regions also character-
ized as subtypes A, G, J and CRF01_AE, with the
subtype J substantially different from that one circu-
lating in Democratic Republic of Congo.91,146,147 Cu-
ban CRF18_cpx and CRF19_cpx that exhibit multi-
ple segments of African subtypes A, D, G and H, were
recently described.19
Recombinations where virus are discordant in gene
regions but they do not resemble any previously
known CRFs are defined as Unique Recombinant
Forms (URFs). Most URFs are detected in regions
where multiple subtypes and CRFs co-circulate.83,133
There are URFs involving more than two subtypes or
also including CRF genomic fragments. The first
CRF01_AE/B recombinant identified in Thailand
was isolated from an individual with both hetero-
sexual and IDU exposure and the full-length genome
showed the strain to be mostly subtype B with the
gp120 of envelope from CRF01_AE. It is likely that
a similar process occurred to generate the recombinant
CRF01_AE/B in Georgia, USA, composed also of HIV-
1 subtype B and CRF_AE.149 CRF01_AE/B has been
disseminated also in Malaysia.150 In Cameroon, where
recombinant CRF02_AG accounts for 60% of preva-
lence, followed by subtype A with 13%, a new com-
plex recombinant CRF02_AG/A is the newest vari-
ant originated.142,149,152 A novel recombinant between
Ukrainian subtype A and African CRF06_cpx origi-
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nated in early 2000s the mosaic CRF06_cpx/A that
is disseminating in Estonia.156 In Switzerland, a new
intermixed CRF11_cpx/B has also disseminated.153
And in Cuba, a intermixed recombinant named
CRF18_cpx/CRF19_cpx was recently recovered.19
Epidemiological studies have showed that HIV-1
subtypes and CRFs are segregated among people
with different risk behaviors.30,31 A multicenter sur-
vey in Taiwan from 1988 to 1998 showed that among
heterosexual and homosexual men the subtype B
infection corresponded to 52% and 78% respec-
tively, and CRF01_AE infections, 44% and 21%
respectively. In this same study, a comparison be-
tween subtype B and CRF01_AE infections in fe-
males and males showed significant differences,
68% in men versus 14% in women for the subtype
B, and 30% in men versus 70% in women for the
CRF01_AE. In regard to IDU AIDS-patients, the same
authors found the proportion of subtype B and
CRF01_AE equal to 67% and 33%, respectively.24
This interesting Taiwanese study provides param-
eters to understand differences in the distribution of
HIV-1 subtypes and recombinant forms according
to regional epidemics and human behaviors.
Several authors have acknowledged that in the early
1980s when the HIV-1 epidemic started, pure subtypes
were prevailing, while CRFs have increased in the
1990s. However, when HIV subtypes were initially
genetically characterized in the early 1990s, the first
identified viruses were assumed to represent pure
subtypes. The viruses found afterward were then com-
pared to these prototypic strains. Recent study in-
cluding serum samples collected in the mid-1980s in
Kinshasa (Democratic Republic of Congo) showed
that substantial intersubtype recombination was al-
ready high in 1980s, when HIV-1 viruses were ini-
tially classified. Thus, at least some of the recombinant
viruses mainly in Central Africa were likely classi-
fied as pure subtypes after being exported from Af-
rica and establishing regional epidemics in other parts
of the world.62
INTRA-SUBTYPES
The genomic region env gp120 of HIV-1 has a pattern
structure of five variable regions named from V1 to
V5 in loop form, interspersed with five conserved
regions C1-C5. Into this complex structure the V3
loop is a region which has been designated the prin-
cipal neutralizing determinant. Virus neutralizing
antibodies are elicited by amino acid sequences en-
compassing the V3 loop. In infected individuals, B-
lymphocytes as well as T-lymphocytes responses are
directed to the V3 loop. Thus, V3 loop is presumed to
play an important role in the early stages of infec-
tion, perhaps by interfering with the interaction of
gp120 and CD4 and/or a distinct coreceptor.150
The V3 region of gp120 contains determinants for
coreceptor affinity and cell tropism as well as immune
evasion, and is associated with a preferential use of the
CCR5 coreceptor, which is also characteristic of most
vertically transmitted HIV-1 viruses. The amino acid
sequence of V3 loop is a variable domain in the gp120
subunit of HIV-1, containing 35 amino acids arranged
in a disulfide loop involving residual Cys301 and
Cys336 interval. This domain plays an important role
in regulating several biological properties of the virus
such as cell tropism, cytopathicity, syncytium forma-
tion and fusogenicity. Deletions in the V3 loop abro-
gate viral infectivity. The variable domain V3 loop
possesses relative conserved subdomains as well as
variable subdomains located at the top or crown of the
loop. Genetic studies have showed that the conserved
amino acids in the V3 loop influence several proper-
ties of HIV-1 that are controlled by the env gene. How-
ever, mutations as substitutions and small deletions in
V3 do not affect the ability of gp120 to interact with
CD4 receptors. Genetic variability into a determined
subtype may introduce diversified motifs character-
ized by V3 loop amino acids and alterations in deter-
mined sequence of amino acids in the crown of V3
loop serves as indicative of the geographic origin of a
certain mutant HIV-1. Using C2V3C3 env region nu-
cleotide sequencing, several amino acid motifs from
the V3 loop crown have been determined, showing wide
spectrum of phenotypes into a same subtype and a
same geographical territory.57,66
The subtype B strains of Spain18 revealed a preva-
lent octamer HIGPGRAF (30%) followed by
PIGPGRAF (9%) and NIGPGRAF (6%). In Switzer-
land, several motifs were found into the subtype B,
characterized by the predominant motif IGPGRAF
(84%) and other tetrameric sequences of amino ac-
ids GPGR and GWGR.132
Korean subtype B strains are characterized by the
tetrameric motifs GPGR (55%), GPGS (20%), and
GPGQ, GPGG, GQGR and APGS (one case each,
5%).103 Current subtypes B in Thailand have predomi-
nantly octameric motifs HIGPGKAF, HIGPGRAF and
PIGPGAFF at the top of V3 loop. Other Thai subtype
named B
B
 is identif ied by HLGPGQAW and
PLGPGQAW octameric motifs also present in
Myanmar and China.20
In Brazil subtype B strains (or B
Br
) present predomi-
nantly GPGGAF motif that circulate also in other South
American countries including Argentina, Uruguay and
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Venezuela.13 Another subtype B with V3 loop motif
GPGRTW was recently described in Venezuela.21 Bra-
zilian subtype C (or C
Br
) has as a characteristic tetramer
GPGQ,13 also found in Portugal,36 Japan,99 and India.80
In relation to the subtype F, Brazilian F
Br
 possesses
GPGR motif13 that has a small difference compared to
the Romanian subtype F
R
 with predominant GPGQ
motif, occasionally also observed in Brazil.7
The different motifs found in subtypes have immedi-
ate implications also in the originated CRFs. A new
B/F recombinant diverse of the South American
CRF12_BF was recently identified into Venezuelan
strains, and involves motifs GPGRVV from sub-
subtype F1 and GPGRTW and GPGGAF from differ-
ent subtypes B. The presence of mosaic genomes high-
lights the need to improve subtyping protocols with
the molecular analysis of at least two distinct viral
regions to identify the circulant recombinants forms
and dual infection with different subtypes, and a
HMA env/gag protocol has been recently proposed
for this confirmatory study.21
The genetic variability of HIV poses special prob-
lems for HIV diagnosis, treatment and HIV vaccine
development. It is therefore important to monitor
the distribution and dynamics of HIV subtypes at a
global level, and this is an objective of the WHO-
UNAIDS – sponsored “Network for HIV Isolation
and Characterization”.35,65
RECOMBINATION BETWEEN HIV GROUPS
Due to the high degree of divergence between HIV
groups M and O it had been suspected that homolo-
gous recombination between HIV groups may not be
possible. However, recent reports have described
recombinant intergroup M/O in three different pa-
tients from Cameroon. These M/O mosaic viruses were
proved to replicate well in vivo and in vitro, and can
even become the predominant variant within the pa-
tient’s viral population.108,133
Dual infections with HIV-1 group M and group O
have been recently identified in Cameroon152 among
AIDS patients. The amplification of both group M
and O genomic sequences from all four genome re-
gions (gag, pol, env gp120-V3 and env gp 41-IDR)
from two distinct specimens had suggested the pres-
ence of at least two viruses, with both group M- and
O-derived sequences across the full-genome. One
specimen contained a group M CRF02_AG virus and
a group O clade V virus, and other specimen con-
tained a group M recombinant of U (unclassified),
CRF02_AG and subtype A, and a group O clade Ib
virus. A third and more complex specimen contained
a group O clade IV virus together with a group M/O
recombinant of M CRF02_AG and O clade IV.
Other types of dual infections including HIV-1 and
HIV-2 have also frequently been reported in Central
Africa regions where both viruses co-circulate, how-
ever, until now, no recombinants between these two
viruses have been described. Probably the level of
genetic divergence between HIV-1 and HIV-2 strains
may be too high for successful recombination, al-
though this possibility cannot be entirely excluded.
There is no protective effect of HIV-2 against subse-
quent HIV-1 infection. Instead, subjects who have HIV-
2 infection are at a substantially higher risk of ac-
quiring HIV-1 infection, whether for behavioral or
biological reasons.62,107,139,152
Dual infections may represent either: (a) concurrent
infection of two or more viral strains occurring at or
near the same time; or (b) sequential superinfection
of a second viral strain after primary seroconversion
to the initial strains. A superinfection is defined as
the re-infection of an individual after a primary HIV-
1 infection, with a heterologous strain belonging to
the same or different subtype as the primary strain.
Dual infections and recombinants involving differ-
ent strains or clades of HIV-1 have been reported over
the past decades, then it was not clear how frequently
these events occur. Dual infection and superinfec-
tion have been reported in a handful of HIV-1 in-
fected individuals. Characterization of new CRFs
and/or URFs in increasing numbers over recent years
has suggested that co-infection and superinfection
are occurring relatively frequently.56,70,153
Recombination between highly divergent groups
within lentiviruses has also been discussed. Group N
forms are an independent lineage most closely related
to but still distant from group M. Genomic analyses
have showed that group N viruses cluster more closely
with a chimpanzee virus (SIV
cpz
). Thus, some authors
have suggested that group N viruses are probably the
result of a recombination event between an SIV
cpz
 like
and an HIV-1 like viruses, which would corroborate
with a substantial zoonotic transmission from chim-
panzee to human. Group M and O strains as divergent
recombination could contribute substantially to the
emergence of new HIV-1 variants, and would have im-
portant implications both for diagnosis by serological
and molecular testing, treatment with antiretroviral
drugs and also for vaccines production.27,41,62,108,109
CONCLUSIONS
Worldwide distribution of HIV subtypes and other
intermixed variants is a dynamic and unpredictable
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process and contributes substantially to the global
AIDS pandemic. Prevalence rates of different subtypes
implicate in the proportion of new recombinant vi-
ruses. The probability of certain population groups
acquiring multiple infections and transmitting their
viruses further, and the fitness of any mosaic viruses
generated also contribute with the proportion of
recombinant viruses. Genomic recombination of HIV
strains may introduce genetic and biological conse-
quences that are far greater than those resulting from
the steady accumulation of single mutations.
A consistent genetic classification of subtypes, CRFs
and other recombinant genomes bears important im-
plications for monitoring the pandemic, vaccine de-
signs, and detection of genetic determinants related
to a particular HIV. Studying HIV genetic variation at
the global level is needed, not only to learn the ori-
gins and understand the epidemiology of HIV-1, but
also to identify the emergence of subtypes, CRFs,
and intra-subtypes that may be more readily trans-
mitted or have altered virulence. Thus, it ensures that
vaccine antigens are directed against strains of the
viruses that are currently circulating within specific
populations. Several countries have been selected as
World Health Organization field site for HIV-1 vac-
cine trials programs, and priority has been given to
molecular investigation of the prevalence and genetic
diversity of HIV-1 strains circulating in the countries.
Genomic variation studies are important for devel-
oping AIDS vaccines and also predicting the global
evolution of HIV.
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